Profile
Laurent Audoly is the founder of Cytovia Therapeutics, Inc., Incendia Therapeutics, Inc. Current positions include Non-Executive Director at Ixaka Ltd. and Director at Cytovia, Inc. (Massachusetts).
Former roles include Chief Executive Officer at BE Therapeutics, Inc., President, Chief Executive Officer & Director at Kymera Therapeutics, Inc., Director-Research & Development Inflammation at MedImmune LLC, Biologics Research Site Lead at Merck & Co., Inc., Senior Research Scientist-Inflammation Department at Pfizer Inc., and Chief Scientific Officer at Pieris AG.
Education includes a doctorate from Vanderbilt University and an undergraduate degree from the University of South Florida.
Laurent Audoly active positions
| Companies | Position | Start |
|---|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Founder | - |
Cytovia Holdings, Inc.
Cytovia Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages on developing therapies to address unmet medical needs in oncology | Director/Board Member | - |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Director/Board Member | - |
Former positions of Laurent Audoly
| Companies | Position | End |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Executive Officer | 2019-05-31 |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Chief Executive Officer | 2023-11-06 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Training of Laurent Audoly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Health Technology |
Cytovia Holdings, Inc.
Cytovia Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages on developing therapies to address unmet medical needs in oncology | Health Technology |
- Stock Market
- Insiders
- Laurent Audoly
















